title: Oral N-acetylcysteine reverses hyperoxia-related cough suppression in guinea pigs.
abstract: Hyperoxia-induced lung injury is well known in animal and human studies. We have previously shown that hyperoxic exposure of guinea pigs is associated with suppression of cough reflex. The goal of this study was to determine the effects of oral N-acetylcysteine (NAC) on hyperoxia-induced oxidative stress in lung tissue directed on cough reflex. The experimental group was pretreated with NAC daily for 7 days and subsequently exposed to 100% O2 for 60 h. Hyperoxic group inhaled 100% O2 only. The control group was exposed to normoxia. Cough was induced by inhalation of citric acid aerosol before and after exposure to oxygen. Cough was also induced by mechanical stimulation of airways in anesthetized animals just after the end of oxygen exposure. Our results showed a significant decrease (P=0.002) in citric acid-induced cough in hyperoxic animals and reversal of that effect in animals pretreated with NAC. In addition, there was a significant interaction between antioxidant therapy and hyperoxia (P=0.005). NAC also reversed the hyperoxia-induced inhibition of mechanically-induced cough. In conclusion, our results indicate that NAC attenuated hyperoxia-induced down-regulation of chemically and mechanically-induced cough.
authors.affiliation: Department of Pathophysiology, Jessenius Faculty of Medicine, Comenius University, Martin, Slovakia. brozmanova@jfmed.uniba.sk
authors.forename: M
authors.initials: M
authors.lastname: Brozmanova
authors.forename: J
authors.initials: J
authors.lastname: Plevkova
authors.forename: V
authors.initials: V
authors.lastname: Bartos
authors.forename: L
authors.initials: L
authors.lastname: Plank
authors.forename: M
authors.initials: M
authors.lastname: Javorka
authors.forename: J
authors.initials: J
authors.lastname: Masar
authors.forename: M
authors.initials: M
authors.lastname: Tatar
mesh_terms: D000111:Acetylcysteine / Q000008:administration & dosage*; D000284:Administration, Oral; D000818:Animals; D000975:Antioxidants / Q000008:administration & dosage*; D019343:Citric Acid; D003371:Cough / Q000209:etiology / Q000378:metabolism / Q000503:physiopathology / Q000517:prevention & control*; D004195:Disease Models, Animal; D006168:Guinea Pigs; D018496:Hyperoxia / Q000150:complications / Q000188:drug therapy* / Q000378:metabolism / Q000503:physiopathology; D008168:Lung / Q000187:drug effects* / Q000294:innervation / Q000378:metabolism / Q000503:physiopathology; D008171:Lung Diseases / Q000188:drug therapy* / Q000209:etiology / Q000378:metabolism / Q000503:physiopathology; D008297:Male; D018384:Oxidative Stress / Q000187:drug effects*; D010812:Physical Stimulation; D012018:Reflex / Q000187:drug effects*
chemical_list: D000975:Antioxidants; D019343:Citric Acid; D000111:Acetylcysteine